Executive Director
Mr. Zhang Feng
Appointed as the chairman of the Board and compliance officer of the Company since June 2011, and was appointed as the authorized representative of the Company on 8 February 2021. He obtained an MBA degree from University of Technology, Sydney. Mr. Zhang studied in Göteborg University, Sweden. He was a member of the 13th National Committee of Chinese People’s Political Conference, a committee member of the 10th and 11th and a standing committee member of the 12th Jilin Municipal Provincial Committee of the Chinese People’s Political Consultative Conference, the deputy chairman of the 10th, 11th and 12th sessions of Jilin Youth Federation (吉林省青年联合会), the president of the 8th session of and the honorary president of the 9th session of council of Jilin Province Youth Entrepreneurs Association (吉林省青年企业家协会) and the part-time deputy chairman of the 11th Jilin Federation of Industry and Commerce (吉林省工商联). Mr. Zhang was the general manager of Shenzhen Neptunus Pharmaceutical Co., Ltd. (“Neptunus Pharmaceutical”) and Shenzhen Neptunus Tongai Pharmaceutical Manufacturing Company Ltd. and the deputy general manager and chief branding and marketing officer of Shenzhen Neptunus Bio-engineering Company Limited (“Neptunus Bioengineering”). He is currently the deputy chairman and non-independent director of the 9th session of the board of directors and president of Neptunus Bio-engineering, the director of Shenzhen Neptunus Group Company Limited (“Neptunus Group”), Shenzhen Quanyaowang Technology Company Limited (深圳市全药网科技有限公司) and Ascendent BioTechnology Company Limited, the chairman of the board of directors of Shenzhen Neptunus Changjian Pharmaceutical Co., Ltd. (“Neptunus Changjian”), the chairman of the board of directors and the legal representative of Neptunus Pharmaceutical, the director of Fuzhou Neptunus Fuyao Pharmaceutical Co., Ltd. (“Neptunus Fuyao”) and Fuzhou Neptunus Jinxiang Chinese Pharmaceutical Company Limited（“Neptunus Jinxiang”）and the chairman of the board of directors and director of several other companies.
Mr. Huang Jian Bo
Appointed as an executive director of the Board, joint company secretary and authorized representative of the Company since June 2020, vice general manager of the Company since 24 April 2020 and the Board secretary and the financial controller of the Company since 13 May 2020. Mr. Huang graduated from Hunan University with a bachelor’s degree in economics and majoring in finance and is a member of the Chinese Institute of Certified Public Accountants. He has extensive experience in listing operations, financial management and investment management. Mr Huang has worked in the Company during the period from February 2003 to April 2016, and served as the chief financial officer, joint company secretary, Board secretary and authorised representative of the Company. He was the financial controller of each of Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd. (安徽九华华源药业有限公司) and Shenzhen Ainengsen Technology Co., Ltd. (深圳爱能森科技有限公司). Mr. Huang is currently a director of Neptunus Changjian and the chairman of supervisory committee of Neptunus Zhongxin.
Non-Executive Director
Mr. Zhang Yi Fei
Appointed as a non-executive director of the Company since 1 March 2021. Mr. Zhang obtained his bachelor’s degree in Technical Economics in 1996 and a master’s degree in Management Science and Engineering in 2015 from the School of Management, Harbin Institute of Technology. He previously served various roles, including secretary of the president office of Shenzhen Neptunus Group Company Limited, sales manager of Sanya branch, regional sales manager of Heilongjiang province, manager of the northeast region, nation-wide commercial director, assistant general manager and operations director, director and the deputy general manager of Neptunus Bio-engineering. He had also acted as the general manager of Zhejiang Huafang Life Technology Co., Ltd. (浙江华方生命科技有限公司). Mr. Zhang is currently the executive vice president and non-independent director of Neptunus Bio-engineering, the legal representative, chairman of the board of directors and general manager of Jilin Neptunus Yinhe Pharmaceutical Investment Co., Ltd., the chairman of the board of directors of Neptunus Fuyao and Neptunus Zhongxin, and a director of several other companies.
Ms. Yu Lin
Appointed as a non-executive director of the Company since February 2005. Ms. Yu graduated from Sun Yat-sen University of the PRC, and has more than 30 years of experience in biochemical and pharmaceutical industries in the PRC. Ms. Yu was the director and vice-president of Neptunus Bio-engineering and was responsible for the research and development of new products. Currently she is a director of Shenzhen Neptunus Pharmaceutical Technology Research Company Limited (“Neptunus Research”), Neptunus Pharmaceutical and Neptunus Zhongxin.
Mr. Shen Da Kai
Appointed as a non-executive director of the Company since 25 June 2020. Mr Shen is an accountant and has an executive master of business administration degree. Mr. Shen obtained the qualification of secretary of the board of directors of Shenzhen Stock Exchange in 2008. He was a material accountant and cost accountant of Guangdong Instrument Co., Ltd. (广东仪表有限公司), the manager of the financial department of Shenzhen Miji Electronics Co., Ltd. (深圳弥基电子有限公司), general ledger accountant and financial supervisor of the financial management department, and leader of the finance team of the SAPR3 project of Shenzhen SEG Samsung Glass Co., Ltd (深圳赛格三星股份有限公司), senior manager of the financial department and securities affairs representative, deputy director of the financial centre of Neptunus Bioengineering, and the executive deputy general manager, director and vice president of Shenzhen Neptunus Jiankang Technology Development Co., Ltd. He is currently the non-independent director, vice-president and chief financial officer of Neptunus Bio-engineering, and concurrently the chairman of the board of directors, legal representative and general manager of Shenzhen Neptunus Yinhe Pharmaceutical Investment Co., Ltd. and a director of several other companies.
Mr. Jin Rui
Appointed as a non-executive director of the Company since 13 May 2022. Mr. Jin obtained a bachelor’s degree from Nanjing University in 2007 and a master’s degree from Zhejiang University in 2013. Mr. Jin previously served various roles in the management level in a number of companies, including the assistant president of Holley Group Co., Ltd., the vice president of Holley Pharmaceutical Group Co., Ltd, and a director of Zhejiang Wazam New Materials Co., Ltd. and Anhui Neptunus Pharmaceutical Group Co., Ltd. He is currently the vice president and nonindependent director of Neptunus Bio-engineering and a director of Neptunus Fuyao, Neptunus Jinxiang and several other companies.
Independent Non-Executive Directors
Mr. Yick Wing Fat, Simon
Appointed as an independent non-executive director of the Company since August 2005. Mr. Yick holds a bachelor’s degree in business administration, majoring in accounting, from the Chinese University of Hong Kong. He is a fellow member of both the Hong Kong Institute of Certified Public Accountants and the Association of Chartered Certified Accountants in England. Mr. Yick has more than 30 years of experience in auditing, direct investment, investment banking and corporate advisory services. In addition, Mr. Yick was an independent non-executive director, the convener of the nomination committee and a member of the strategy committee of Chengdu Xingrong Environment Co., Ltd. (the shares of which are listed on the Shenzhen Stock Exchange) from August 2015 to August 2020. And Mr. Yick was an independent non-executive director, the chairman of the remuneration and nomination committee and a member of the audit and compliance committee of Nexteer Automotive Group Limited (the shares of which are listed on the Main Board of the Stock Exchange) from August 2017 to June 2020. Mr. Yick is currently the independent non-executive director and chairman of audit committee of Shanghai International Shanghai Growth Investment Limited, China Shuifa Singyes Energy Holdings Limited (formerly known as “China Singyes Solar Technologies Holdings Limited”) and Meta Media Holdings Limited (formerly known as “Modern Media Holdings Limited”) (the shares of these three companies are listed on the Main Board of the Stock Exchange).
Mr. Poon Ka Yeung
Appointed as an independent non-executive director of the Company since August 2005. Mr. Poon obtained his bachelor’s degree in mathematics with minor in economics and marketing from the Chinese University of Hong Kong in 1989 and was further admitted to the MBA degree by the University of Hull, United Kingdom, in 1996. Mr. Poon has been appointed as an Honorary Institute Fellow of the Asia-Pacific Institute of Business of the Chinese University of Hong Kong since April 2002. He has been teaching marketing-related subjects for the master’s degree in science program, MBA program and Global Executive MBA program (OneMBA) of the Chinese University of Hong Kong. Since June 2008, he has been appointed as visiting Adjunct Associate Professor in the Department of Marketing of the Chinese University of Hong Kong. In addition, Mr. Poon has been appointed as an independent non-executive director and a member of audit, remuneration and nomination committees of Great Eagle Holdings Limited (the shares of which are listed on the Main Board of the Stock Exchange) since March 2016. On 22 December 2021, Mr. Poon was redesignated to an executive director of Great Eagle Holdings Limited, presiding over the investment in innovative technology.
Mr. Zhang Jian Zhou
Appointed as an independent non-executive director of the Company since January 2016. Mr. Zhang graduated from China Youth University of Political Studies with a B.A. degree in 1990, from Beijing Foreign Studies University with a LL.B degree in 1992, and from Boston University with a LL.M degree in 2002. He had been an assistant professor of International Trade Law at Guangdong University of Technology from 1992 to 1993. Mr. Zhang has been in private practice since 1993 when he was qualified to practice law in the PRC. He is now a partner of Beijing Anjie (Shenzhen) Law Firm.
Board members
——
Shenzhen Haiwang intlong Biotechnology Co., Ltd
Tel: (86) 75526411869
Fax: (86) 7558639160
Post code: 518000
Focus on us
Shenzhen Haiwang intelon Biotechnology Co., Ltd. All Rights Reserved
吴医师